← Back to Search

Diagnostic Test

Contrast enhanced ultrasound for Abdominal Aortic Aneurysm

N/A
Waitlist Available
Led By Edward Grant
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1. Aged 18 or over 2. Able to give informed consent 3. Undergone an EVAR or FEVAR for abdominal aortic aneurysms 4. Expected to have CTA
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Study Summary

This trial will compare the effectiveness of two different types of imaging scans for abdominal aortic pathology. One type of scan uses radiation and potentially nephrotoxic iodinated contrast, while the other type of scan (contrast ultrasound) does not use radiation and has no potential for nephrotoxicity.

Eligible Conditions
  • Abdominal Aortic Aneurysm

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Is there any endoleak positive on CEUS or various phases of the CTA but negative on CTA in the delayed phase
To determine the sensitivity and specificity for CEUS and various CTA phases when using delay phase of CTA as the gold standard

Trial Design

1Treatment groups
Experimental Treatment
Group I: contrast enhanced ultrasoundExperimental Treatment1 Intervention
CEUS will be performed at one month post-op, six months post-op and at one year.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contrast enhanced ultrasound
2019
Completed Phase 2
~10

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
906 Previous Clinical Trials
1,596,288 Total Patients Enrolled
Edward GrantPrincipal InvestigatorUniversity of Southern California

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Contrast Enhanced Ultrasound Endoleak Identification and Classification
Edward Grant 2020. "Contrast Enhanced Ultrasound Endoleak Identification and Classification". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04615559.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top